UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000048751
Receipt number R000055506
Scientific Title Investigation of prism adaptation method using VR
Date of disclosure of the study information 2022/08/25
Last modified on 2023/08/07 14:42:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of prism adaptation method using VR

Acronym

Investigation of prism adaptation method using VR

Scientific Title

Investigation of prism adaptation method using VR

Scientific Title:Acronym

Investigation of prism adaptation method using VR

Region

Japan


Condition

Condition

healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine how the different number of targets in prismatic adaptation therapy affects the degree of adaptation and the adaptation process.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Manual Straight Ahead
Before and after intervention and After 2 hours

Key secondary outcomes

Adaptation Index
Before and after intervention and After 2 hours


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Dose comparison

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

The declination of the PA task was set at approximately 10 degrees to the right. Subjects were asked to perform 100 trials of pointing to a single target in the frontal plane. They also performed 30 pointing trials each with no deviation angle before and after the PA task.

Interventions/Control_2

The declination angle of the PA task was set at approximately 10 degrees to the right. Subjects performed 100 trials of pointing to the two targets on the left and right. Before and after the PA task, subjects also performed 30 pointing trials with no deviation angle set before and after the PA task.

Interventions/Control_3

The declination angle for the PA task was set at approximately 10 degrees to the right. Subjects were asked to perform 100 pointing trials to three targets in front and to the left and right. Before and after the PA task, in which no deviation angle was set, subjects performed 30 pointing trials each.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

Right-handed normal adult

Key exclusion criteria

1) visual impairment, 2) cerebrovascular disease, 3) significant motor system disease in the right upper extremity

Target sample size

57


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Matsuo

Organization

Kumamoto Health Sciences University

Division name

Faculty of Health Sciences

Zip code

8615598

Address

325 Izumimachi,Kitaku,Kumamoto to city,Japan

TEL

0962752111

Email

matsuo-ta@kumamoto-hsu.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Matsuo

Organization

Kumamoto Health Sciences University

Division name

Faculty of Health Sciences

Zip code

8615598

Address

325 Izumimachi,Kitaku,Kumamoto to city,Japan

TEL

0962752111

Homepage URL


Email

matsuo-ta@kumamoto-hsu.ac.jp


Sponsor or person

Institute

Kumamoto Health Sciences University

Institute

Department

Personal name



Funding Source

Organization

Kumamoto Health Sciences University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kumamoto Health Science University Life Science Ethics Review Board

Address

325 Izumimachi,Kitaku,Kumamoto to city,Japan

Tel

0962752111

Email

kikaku@kumamoto-hsu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

桜十字福岡病院(福岡県)


Other administrative information

Date of disclosure of the study information

2022 Year 08 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

57

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 01 Month 31 Day

Date of IRB

2022 Year 02 Month 14 Day

Anticipated trial start date

2022 Year 04 Month 01 Day

Last follow-up date

2022 Year 09 Month 10 Day

Date of closure to data entry

2022 Year 09 Month 12 Day

Date trial data considered complete

2022 Year 10 Month 01 Day

Date analysis concluded

2022 Year 11 Month 30 Day


Other

Other related information



Management information

Registered date

2022 Year 08 Month 25 Day

Last modified on

2023 Year 08 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000055506


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name